baber/WOPTO huggingface dataset:
Patent NZ-569002-A (NZ)
Title: Distributing overhall control of mesh AMR LAN networks to WAN interconnected collectors
Inventor: KELLEY RAYMOND H
IPC: H04W60/00
Filed: 2006-12-21
Abstract: A method of coordinating the migration of a node from a first communication device to a second communication device across a network is disclosed. The node can be a metering node and the first and second communication devices can be a first and second collectors respectively. The method comprises the following steps performed at the second communication device: updating a mapping table to include an identifier of the node after the node has migrated from the first communication device to the second communication device; using an address of the first communication device to determine information about the node; leaving a forwarding address of the second communication device at the first communication device; updating the node with an address of the second communication device; and notifying a host system that the node has migrated.
Patent NZ-575593-A (NZ)
Title: A connector system using a locking mechanism on the male part that engages the threads of the female part
Inventor: WELLS MICHAEL P
IPC: F16L25/06
Filed: 2007-09-24
Abstract: A male coupling (300) that is connectable to and separable from a female threaded coupling (e.g., a female threaded port) is disclosed. The female threaded coupling includes a sealing surface and a receiving portion sized to receive at least a portion of the male coupling, where the receiving portion has internal threads provided therein. The male coupling includes a body (310) having a passageway extending therethrough and a locking member (346) (e.g., ratcheting or non- ratcheting) disposed about the body and configured to move between locking and releasing positions. The locking member has a retaining formation configured to engage the internal threads of the female threaded coupling when the locking member is in its locking position. The male coupling also includes an axially movable sleeve (366) disposed about the body and an annular seal disposed about the sleeve. After insertion of the male coupling into the female threaded coupling, the retaining formation of the locking member engages one or more of the internal threads in the female threaded coupling when the locking member is in its locking position. Upon movement of the sleeve towards the female threaded coupling, the annular seal is compressed against the sealing surface of the female threaded coupling.
Patent NZ-581893-A (NZ)
Title: False formwork for moulding concrete panels having a false skim coat
Inventor: SLADOJEVIC ROBERT
IPC: B28B7/00
Filed: 2007-10-31
Abstract: Disclosed is a concrete casting false formwork system when used to form a concrete panel. The system includes a number of concrete sideforms which are able to be interconnected to define a perimeter of an opening in the concrete panel to be cast. The system includes a support structure carried by the sideforms for supporting components used to mould a false skim coat of concrete overlying the opening when the concrete panel is cast. The system also includes an opening demarcation portion carried by one or more of the sideforms. Each opening demarcation portion defines a zone of weakness to demarcate the skim coat of the cast concrete panel from a remainder of the panel and to facilitate removal of the skim coat from the remainder of the panel by breakage along a zone of weakness.
Patent NZ-582555-A (NZ)
Title: Sulfonamides as trpm8 modulators
Inventor: YOUNGMAN MARK A
IPC: A61K31/381
Filed: 2008-07-18
Abstract: Disclosed is a compound of formula (I) e.g. N-(3-Methylbenzo[b]thiophen-2-yl)-4-carbomethoxy-benzenesulfonamide for the treating of inflammatory pain, inflammatory hypersensitivity condition, neuropathic pain, anxiety and/or depression.
Patent NZ-588431-A (NZ)
Title: Using Benzimidazole or Indole compounds with a 1,2-diazole group to Inhibit Alpha-Synuclein Toxicity
Inventor: LINDQUIST SUSAN L
IPC: A61K31/415
Filed: 2005-09-16
Abstract: Disclosed is a compound of formula (V) where the substituents are as disclosed in the description. Also disclosed is the use of a compound of formula (V) in the manufacture of a medicament for inhibiting or preventing alpha-synuclein toxicity and/or fibril formation, inhibiting or preventing alpha-synuclein fibril growth, and/or causing disassembly, disruption, and/or disaggregation of alpha-synuclein fibrils and a-synuclein-associated protein deposits. Examples of compound of formula (V) include; N-[1-(1H-benzimidazol-2-yl)-3-methyl-1H-pyrazol-5-yl]-4-chlorobenzamide and Ethyl{ [1-(1H-benzimidazol-2-yl)-3-methyl-1H-pyrazol-5-yl]amino} (oxo)acetate. Further disclosed is a composition comprising a compound of formula (V).
Patent NZ-591293-A (NZ)
Title: Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs)
Inventor: ABRAMSON SASCHA DAWN
IPC: A61K35/12
Filed: 2009-08-24
Abstract: Disclosed is an isolated osteogenic placental adherent cell (OPAC), wherein said OPAC is obtained from chorion, and is adherent to tissue culture plastic, and wherein said OP AC is negative for CD200 or is CD200dim, and positive for CD105. Further disclosed is the use of said OPACs in the manufacture of a medicament for treating an individual having multiple myeloma.
Patent NZ-596384-A (NZ)
Title: Anti-human cd52 immunoglobulins
Inventor: ROBERTS BRUCE L
IPC: A61K39/00
Filed: 2010-05-13
Abstract: 596384 Discloses a monoclonal anti-human CD52 antibody, comprising CDR H1: GFPFSNYWMN CDR H2: QIRLKSNNYATHYAESVKG CDR H3: TPIDY CDR L1: KSSQSLLYSNGKTYLN CDR L2: LVSKLDS CDR L3: VQGSHFHT Also claims and antibody which binds to the same epitope on the human CD52 as the antibody disclosed above. Further discloses the use of the antibody for the treatment of a patient who is receiving a transplant, inhibiting angiogenesis or neovascularisation.
Patent NZ-596939-A (NZ)
Title: Control process for an anode baking furnace and adapted furnace using such a process
Inventor: MORALES FRANCOIS
IPC: F23N5/02
Filed: 2010-06-07
Abstract: The disclosure relates to a method for adjusting an oven for baking carbon anodes, including: longitudinal hollow walls in each of which a baking hot gas stream can flow, the hollow walls defining cells therebetween for receiving the anodes to be baked, and a heating system rotating relative to the hollow walls and including an upstream manifold for blowing air into the various walls, a downstream manifold for drawing the gas from the various walls, and at least one heating manifold. The method includes a phase of naturally preheating the walls and the anodes which release volatile combustible materials that burn in the hollow cells as a degassing front in a natural preheating area of the oven downstream from the heating manifold. According to the disclosure, the method comprises modifying the gas stream flowing in the hollow walls so as to control the gas streams (30, 31) passing through a first natural preheating area using the gas streams (31) exiting a second natural preheating area (Z2) in order to control the positioning of the degassing front.
Patent NZ-605176-A (NZ)
Title: Pharmaceutical composition comprising drospirenone and contraceptive kit
Inventor: PERRIN PHILIPPE
IPC: A61K31/585
Filed: 2011-06-28
Abstract: Disclosed is a contraceptive kit comprising one or more packaging units wherein each packaging unit comprises 21 to 28 daily active dosage units and wherein: each daily active dosage unit comprises drospirenone in an amount of from about 2 mg to about 6mg, without estrogen; and drospirenone is in a crystallised form. Also disclosed are kits and compositions wherein a single daily active dosage unit, when orally administered under fasting conditions, provides a pharmacokinetic profile for drospirenone having: a mean tmax ranges from 2.2 h to 6h; and a mean Cmax which is less than about 30 ng/ml.
Patent NZ-618381-A (NZ)
Title: Use of a herbicidal composition for controlling parasitic plants
Inventor: ANGELES ALVAREZ PEDRO GUILLERMO
IPC: A01N57/12
Filed: 2013-01-15
Abstract: Disclosed herein are compositions consisting of: (a) at least one ethylene-releasing compound, particularly 2-chloroethylphosphinic acid (ethephon), and (b) at least one fatty acid ester, particularly lanolin, alone or in combination with one or more excipients, vehicles or additives, and/or (c) one or more noxious agents. The invention also relates to the use of said composition and to methods for controlling parasitic plants and/or hemiparasitic plants that cause infestations in certain trees. The composition of the invention is characterized in that it exhibits a high degree of adhesion to the parasitic and/or hemiparasitic plant is selective and has excellent stability and water-impermeability, allowing the prolonged and constant release of ethylene.
Patent NZ-618667-A (NZ)
Title: Low-odour (meth)acrylic reaction resins
Inventor: HILF STEFAN
IPC: E01F9/04
Filed: 2012-07-02
Abstract: Disclosed are (meth)acrylic reaction resins containing reactive cyclically substituted esters of (meth)acrylic acid selected from the group consisting of glycerol formal(meth)acrylate, trimethylolpropane formal(meth)acrylate and isopropylideneglycerol (meth)acrylate (Solketal methacrylate). The cyclically substituted esters of (meth)acrylic acid above substitute methyl methacrylate (MMA), which constitutes the main part of the odour an thus results in an odourless/low odour resin.
Patent NZ-631500-A (NZ)
Title: Friction reducing polymers
Inventor: PHILIP WATSON
IPC: C09K8/68
Filed: 2014-04-18
Abstract: Described herein are friction reducing polymers comprising two or more recurring units wherein at least one recurring unit is an acrylic acid or acrylamide monomer and at least one recurring unit is a vinyl monomer selected from a vinyl alcohol, a vinyl ester, and a vinyl ether.
Patent NZ-709980-A (NZ)
Title: Equipment for a wheel of a bicycle and corresponding rim
Inventor: MEZADOURIAN GÉRARD
IPC: F03G3/08
Filed: 2014-01-20
Abstract: The present invention relates to a device for a bicycle wheel comprising at least one profiled wing-shaped projection designed to be secured to the inner surface of the rim between two points W1 and Z1; the internal profile of said wing-shaped projection extending along an arc of circle ARC1 of radius R2 and centre P, the radius R2 being such that R2 = 0.6(R1) to 0.8(R1); the centre P of the arc of circle ARC1 being placed at a distance H from said centre O, such that H = 0.1(R1) to 0.2(R1); the at least one profiled wing-shaped projection further comprising a first cutout of a sector having an angle α from the point W1, and a second cutout of a sector having an angle β to be taken from the point Z1; and the angles α and β, which are equal or different, are such that α = 20 deg to 45 deg and β = 20 deg to 45 deg. The profile of the equipment improves the operation of the bicycle by improving the hold of wheel on the axis of symmetry and, consequently, the quality of performance provided by the pedal is optimal and lateral deformation is reduced.
Patent NZ-711219-A (NZ)
Title: Child resistant closure system including hood arrangement for recloseable bag and methods
Inventor: DOWLER ROGER E
IPC: B65D50/06
Filed: 2014-03-10
Abstract: A child resistant zipper closure for a plastic bag includes a zipper closure having a hood arrangement that includes at least a non-removable hood section in covering relation to a first portion of the zipper closure. There can be slider to open and close the closure, and the non-removable hood section will be sized to accommodate the slider. The hood arrangement can include a removable section to expose the zipper closure and allow access to the slider.
Patent NZ-711376-A (NZ)
Title: Heteroaryl compounds and uses thereof
Inventor: D’AGOSTINO LAURA AKULLIAN
IPC: C07D475/00
Filed: 2014-03-14
Abstract: The present invention relates to compounds of formula I below which are useful as inhibitors of protein kinases, containing a cysteine residue in the ATP binding site. The invention further provides for pharmaceutically acceptable compositions comprising therapeutically effective amounts of one or more of the protein kinase inhibitor compounds of formula I and methods of using said compositions in the treatment of cancers and carcinomas.
Patent NZ-716612-A (NZ)
Title: Anti-prlr antibodies and uses thereof
Inventor: NITTOLI THOMAS
IPC: C07K16/28
Filed: 2014-08-20
Abstract: The present disclosure provides antibodies that bind to prolactin receptor (PRLR) and methods of using the same. According to certain embodiments, the antibodies of the disclosure bind human PRLR with high affinity. In certain embodiments, the disclosure includes antibodies that bind PRLR and block prolactin-mediated cell signaling. The antibodies of the disclosure may be fully human antibodies. The disclosure includes anti-PRLR antibodies conjugated to a cytotoxic agent, radionuclide, or other moiety detrimental to cell growth or proliferation. The antibodies of the disclosure are useful for the treatment of various cancers as well as other PRLR-related disorders. The present disclosure also includes antibody drug conjugates comprising an antibody or antigen-binding fragment thereof that specifically binds a class I cytokine receptor, wherein the antibody or antigen-binding fragment thereof is conjugated to a cytotoxic agent. The present invention is useful in treating breast-cancer in a subject.
Patent NZ-728561-A (NZ)
Title: Methods and compositions for targeted genetic modifications and methods of use
Inventor: KUNO JUNKO
IPC: C12N5/0735
Filed: 2015-06-26
Abstract: Methods and compositions are provided for generating targeted genetic modifications on the Y chromosome or a challenging target locus. Compositions include an in vitro culture comprising an XY pluripotent and/or totipotent animal cell (i.e., XY ES cells or XY iPS cells) having a modification that decreases the level and/or activity of an Sry protein; and, culturing these cells in a medium that promotes development of XY F0 fertile females. Such compositions find use in various methods for making a fertile female XY non-human mammal in an F0 generation.
Patent NZ-731002-A (NZ)
Title: Tamper evident closure container
Inventor: HRISCHMANN AARON
IPC: A61M5/00
Filed: 2015-12-09
Abstract: A closure container that can house a preset drug applicator in an easily accessible manner with tamper evidencing means. The closure container contains a plurality of dosing ribs and a retainer to retain the syringe in a preset dosage amount and preferably has a window to view the barrel of the syringe. The container further contains a fastener with a pull-tab wherein removing the pull-tab causes a visible tear in the fastener. The container is also configured to be removably attached to and stacked with other closure containers.
Patent NZ-743573-A (NZ)
Title: Herbicidal compositions containing 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or derivative thereof, florasulam or derivative thereof, and pyroxsulam or derivative thereof
Inventor: MANN RICHARD K
IPC: C07D213/79
Filed: 2016-12-02
Abstract: Provided herein are herbicidal compositions and methods using a mixture comprising (a) the compound of formula (I) or an agriculturally acceptable salt of ester thereof, (b) florasulam or an agriculturally acceptable salt thereof, and (c) pyroxsulam or an agriculturally acceptable salt thereof. The compositions provide weed control of undesirable vegetation in areas including, but not limited to, annual crop, cereal crop, fallow-bed, non-crop, IVM, range and pasture, tree and vine crop, perennial crop, fruiting crop, and plantation crop areas.
Patent NZ-744576-A (NZ)
Title: System and method for preparing high purity vanadium electrolyte
Inventor: ZHU QINGSHAN
IPC: B01J8/18
Filed: 2017-01-16
Abstract: Provided are a system and a method for preparing a high purity vanadium electrolyte. Vanadium oxytrichloride is used as a raw material, a low-valence vanadium oxide is prepared by ammonium salt precipitation and fluidization reduction, and a sulfuric acid solution and clean water are added to prepare a high purity vanadium electrolyte at a low temperature under the conditions of supersonic wave-assisted dissolution and activation. Through heat exchange between an ammonium salt and a reduction tail gas and heat exchange between a reduction product and fluidized nitrogen, heat is efficiently used. The ammonia gas in the reduction tail gas is recovered and used for vanadium precipitation so that ammonia gas recycling is realized. An inner member is arranged in a reduction fluidized bed, so that accurate control of the valence of a reduction product is realized. Furthermore, through the use of supersonic wave-assisted dissolution and activation, the vanadium electrolyte is prepared at a low temperature and the electrolyte activity is improved. The system and the method have advantages such as a short process, high efficiency and cleanliness, and stable product quality; and are suitable for large-scale industrial production.
Patent NZ-745425-A (NZ)
Title: G protein-coupled receptor (gpcr) modulation by imipridones
Inventor: ALLEN JOSHUA E
IPC: C07K16/28
Filed: 2017-01-30
Abstract: Imipridones has been found to selectively modulate Class A G protein-coupled receptors (GPCRs), such as the D2-like subfamily of dopamine receptors, and to be useful for the treatment of conditions and disorders in need of such modulation, such as central nervous system cancer with a histone H3 mutation.
Patent NZ-766141-A (NZ)
Title: Isoxazoline parasiticide formulations and methods for treating blepharitis
Inventor: HICKOK SHAWN
IPC: A61K9/70
Filed: 2018-12-14
Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
Patent PT-100992-A (PT)
Inventor: PRIMEAU JOHN LAURENT
IPC: A61P9/00
Filed: 1992-10-22
Abstract: There are disclosed compounds of the general formula I:   <IMAGE> I wherein X is H, NR12R13, OR14, CN, F, Cl, I, Br, perfluoroalkyl, alkyl, alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R14, -(CH2)nCONR12R13; Y is NR15, NR18CR16R17, CR16R17NR15; R1 is 5-tetrazolyl, CO2R14, SO3H, NHSO2CH3, NHSO2CF3; R2, R3 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH perfluoroalkyl, aralkyl, CN, NO2, SO2R19, -(CH2)nCO2R14, -(CH2)nCONR12R13, OR14, F, Cl, Br, I, NR12R13; R4-R11 is H, F, alkyl, alkoxy, alkoxyalkyl, -OCOR14, alkyl-OH, perfluoroalkyl, aralkyl, aryl, CN, NO2, SO2R19, -(CH2)nCO2R14, -(CH2)nCONR12R13, OH, OR14, -NR12R13, any two geminal groups can be O or CH2; R12, R13 is H, alkyl, aralkyl; R14 is H, alkyl, aralkyl, alkoxyalkyl; R15 is H, alkyl, -(CH2)nCO2R14, alkoxyalkyl, aralkyl, -(CH2)nCONR12R13, OR14, perfluoroalkyl, alkyl-OH, -COR14, -CONR12R13; R16, R17 is H, alkyl, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R19, -(CH2)nCO2R14, -(CH2)nCONR12R13; R18 is H, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, OR14, -(CH2)nCO2R14, -(CH2)nCONR12R13, alkyl, -COR14, -CONR12R13; R19 is alkyl, aralkyl; n is 0, 1, 2 or 3; m is 1-5; wherein alkyl is defined as 1-8 carbons, branched or straight chain; perfluoroalkyl is defined as 1-6 carbons; aralkyl is defined as 7-12 carbons or 7-12 carbons substituted with fluorine, bromine or chlorine; aryl is defined as 6-10 carbons or 6-10 carbons substituted with fluorine, bromine or chlorine and the pharmaceutically acceptable salts, solvates and hydrates thereof, which by virtue of their ability to antagonize angiotensin II are useful for the treatment of hypertension and congestive heart-failure. The compounds are also useful for reducing lipid levels in the blood plasma and are thus useful for treating hyperlipidemia and hypercholesterolemia. Also disclosed are processes for the production of said compounds and pharmaceutical compositions containing said compounds.
Patent PT-103863-A (PT)
Title: Cadeira modular, inclinável e de baloiço
Inventor: NUNES LUIS FERNANDO NASCIMENTO
IPC: A47C3/02
Filed: 2007-10-25
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UMA CADEIRA (1) MODULAR, INCLINÁVEL E DE BALOIÇO. É ESSENCIALMENTE CARACTERIZADA POR SER CONSTITUÍDA POR UM PRIMEIRO MÓDULO FORMADO POR UMA BASE DE APOIO (2) E UM SEGUNDO MÓDULO FORMADO POR UMA CADEIRA PROPRIAMENTE DITA (3) CONSTITUÍDA POR UM ENCOSTO (10), UM ASSENTO (11) E UM APOIA-PÉS (12), O PRIMEIRO MÓDULO SUPORTANDO O SEGUNDO MÓDULO ATRAVÉS DE DOIS ELEMENTOS DE LIGAÇÃO E SUSPENSÃO (4), LIGAÇÕES ESSAS QUE PERMITEM A INCLINAÇÃO COM ALTERAÇÃO DA CONFIGURAÇÃO DO CONJUNTO E O BALANCEAR DO SEGUNDO MÓDULO SOBRE O PRIMEIRO.
Patent RO-91212-A (RO)
Inventor: YUTAKA SASAKI
IPC: B01J23/18
Filed: 1984-09-27
Abstract: A process for the production of antimony-containing metal oxide catalysts, comprising preparing a slurry containing as essential components an antimony component, a polyvalent metal compound, and silica sol, heating and drying the slurry to form a solid product, and then calcining the solid product, wherein the antimony component is a mixture of (A) at least one of antimonic acid, polyantimonic acid and the salts thereof and (B) antimony trioxide, and is prepared by mixing (A) and (B) in such a manner that the antimony provided by the (B) constitutes from 0.1 to 70 atomic % of the total amount of antimony and further in an aqueous slurry state. These antimony-containing metal oxide catalysts have superior activity and physical properties, and further reproducibility in the preparation thereof. Thus they are useful for production of aldehydes and acids through oxidation, nitriles through ammoxidation, and dienes, unsaturated aldehydes and unsaturated acids through oxidative dehydrogenation.
Patent RU-94012694-A (RU)
Inventor: SHUL GIN L M
IPC: B62D55/20
Filed: 1994-04-12
Abstract: FIELD: transport engineering; crawler vehicles. SUBSTANCE: track chain has cast links connected by pins - torsion bars made in form of steel plates installed in elongated holes of lugs. Ribs of plates engage through retainers with lugs. Retainers play part of bearing within the limits of link turning angle. Working force from pin-torsion bar is transmitted through roller in hinge joints with single-leaf pin - torsion bar arranged in holes of lugs between two rubber pads. Roller operates as sector of ball bearing at alternating displacements. Angular displacements of links are provided by hinge joints owing to elastic deformation of rubber pads and pins - torsion bars. Thanks to it there are no friction losses in hinge joints and track chain operates at insignificant power losses in hinge joint which do not suffer from wear. Track chain elastically engages with soil in sections between road wheels owing to twisting of pins - torsion bars. If pins - torsion bars are calculated correctly, peaks of specific pressure on soil under road wheels are completely eliminated making the proposed track chain similar to pneumatic track. Bending of pins - torsion bars under action of vertical forces is limited by grousers located in hinge joint area and provided with side projections and side cutouts with clearance enclosing side projections. EFFECT: enlarged operating capabilities. 5 cl, 5 dwg